Market OpportunityThe company believes there is a significant market opportunity, with an estimated 25,000 to 30,000 adults in the U.S. getting cochlear implants annually by 2026, representing a market opportunity exceeding $750 million.
Product InnovationEnvoy has developed the Acclaim CI, a fully implanted cochlear implant that does not require any external component to be worn on the ear.
Regulatory ApprovalThe Acclaim CI received approval for its IDE application with the FDA to begin clinical testing and has already started trials with participants.